Genentech Charges $55,000 for a Year's Supply of Avastin

The Best Savings Rates, CD Rates, and More

	Email to friend
	Print

Share

Other writing by soczie

Article Submitted by: soczie
Stocks - Options - Mutual Funds

Tags: Drugs, Genentech, Avastin, Hillary, Obama.

Genentech is a remarkable company and Avastin extends people's lives, but a Hillary or Barack Presidency with a Democrat Congress will clearly close down margins like this. I am afraid that it will be two generations before this stock stops falling if one of these two are elected.

Submitted: Jun 20, 2007 Views: 377 Comments: 1 Likes: 8

View Article: http://online.wsj.com/article/SB118100806142024548-search.html?KEYW...

Sponsor Updates and Offers

Related Articles:

Jim Cramer Pushes CV Therapeutics by soczie - Jun 20, 2007
Acquisition rumors Seems to be Causing CVTX to Continue Dramatic Rise by soczie - Jun 21, 2007
Teva Comments on the Biologics Price Competition and Innovation Act of 2007 by JRodgers - Jun 27, 2007
Roche Acquisition of Genentech Makes no Sense At All by JRodgers - Jul 21, 2008
Does Wall Street Have a Death Wish? by soczie - Aug 05, 2008
Federal Reserve Begins First Meeting of 2009 with No Flexibility by soczie - Jan 27, 2009
When Obama Loses, there will be blood on the streets of Chicago by JRodgers - Jul 07, 2008.

Email this story Email to someone | Print Content | Add to reading list

Comments Received:

alexWoj

Genentech is a great company that saves people's lives. They are the Apple of their world. The government and health care industry need to allow them to make a profile in order to support their continued research.

Posted: Jun 23, 2007

Financial products of all nature bear inherent risks and this website is not a financial advisory service; it is a forum for users to share and to compare notes and observations on financial publications. The website provides, free of charge, the technical and logistical apparatus and the medium for users to share and to publish financial information and to comment on publications. As such, the website's operator can not and does not take responsibility for information, observations or opinions of any sort or nature provided by third parties with whom it is not affiliated who use the website to publish, to comment or as a means of solicitation. Users are specifically warned against following any advice related to specific instruments, including, but not limited to, equity securities, that may be provided by other users directly on this site or on web pages to which other users have provided links on this site. BestCashCow.com can not and does not check or verify the qualifications and credentials of users who publish or comment on this site or on linked pages. Users should seek personalized advice from qualified professionals regarding all personal financial issues and evaluate the risks and applicability to their own circumstances of each financial product discussed regardless of who the publisher is or purports to be. Should you, through your use of this site, identify an individual or organization purporting to offer personalized advice, you bear all responsibility to ensure that the individual or organization has the qualifications that they may represent on the website, and that their advice is appropriate for your circumstances. On certain webpages, BestCashCow.com provides information related to rates on US-based savings accounts, CDs, short-term government bonds, and other US cash equivalent securities, also free of charge to internet users for their independent use. The accuracy of this information is not guaranteed, and the information, like all other information on this website, should not be construed to provide investment advice, nor to endorse a financial product of any sort.

The Best Savings Rates, CD Rates, and More

Other writing by soczie

Tags